Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL257121 | 1.00 | APP (0.46) | APPTAAR1TLR8NFE2L2 | |
| SCHEMBL10324102 | 1.00 | APP (0.46) | APPTAAR1TLR8NFE2L2 | |
| SCHEMBL30375126 | 0.80 | APP (0.41) | APPTLR8 | |
| SCHEMBL7983449 | 0.80 | APP (0.41) | APPTLR8 | |
| SCHEMBL15051242 | 0.80 | APP (0.41) | APPTLR8 | |
| SCHEMBL7983453 | 0.80 | APP (0.41) | APPTLR8 | |
| SCHEMBL4894976 | 0.79 | APP (0.41) | APPTAAR1 | |
| SCHEMBL15397070 | 0.78 | APP (0.42) | APPTAAR1NFE2L2 | |
| SCHEMBL15539165 | 0.78 | APP (0.42) | APPTAAR1NFE2L2 | |
| SCHEMBL16795959 | 0.78 | APP (0.42) | APPTAAR1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111419830-B | Phenylalkylcarbamate compounds for use in the prevention or treatment of epilepsy and epileptic related syndromes | 比皮艾思药物研发有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-115996905-A | Phenylalkyl carbamate compounds for use in preventing or treating neurodegenerative diseases | 生物药品解决方案有限公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-109939092-B | Phenyl carbamate compounds for use in preventing or treating pediatric epilepsy and epilepsy-related syndrome | 比皮艾思药物研发有限公司 | 2022-03-22 | — | — | CN | disclosed |